CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cells
Oncology Reports · 2025
DOI: 10.3892/or.2025.9012 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Ryoichi Matsunuma und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Shizuoka 420‑8527, Japan. Hauptthemen laut MEDLINE: Hyaluronan Receptors, Breast Neoplasms, Transforming Growth Factor beta, Pyrazoles. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Breast Surgery, Shizuoka General Hospital, Shizuoka, Shizuoka 420‑8527, Japan.
- Evolutionary Medicine, Shizuoka Graduate University of Public Health, Shizuoka, Shizuoka 420‑0881, Japan.
Zitieren
APA
Matsunuma, R., Kinoshita, K., Imada, S., Sato, S., Hayami, R., & Tsuneizumi, M. (2025). CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cells. Oncology Reports. https://doi.org/10.3892/or.2025.9012
Vancouver
Matsunuma R, Kinoshita K, Imada S, Sato S, Hayami R, Tsuneizumi M. CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cells. Oncology Reports. 2025. doi:10.3892/or.2025.9012
BibTeX
@article{Matsunuma2025,
author = {Matsunuma, Ryoichi and Kinoshita, Kazuo and Imada, Sae and Sato, Shoko and Hayami, Ryosuke and Tsuneizumi, Michiko},
title = {CD44 knockdown and TGF‑β inhibition modulate cell proliferation and invasion in claudin‑low breast cancer cells},
journal = {Oncology Reports},
year = {2025},
doi = {10.3892/or.2025.9012}
}
EUVIMED